Entrada Therapeutics Reports Third Quarter 2024 Financial Results

Go back to Entrada Therapeutics Reports Third Quarter 2024 Financial Results
(NASDAQ: TRDA) Delayed: 7.54 -0.06 (0.79%)
Previous Close $7.60    52 Week High
Open $7.64    52 Week Low
Day High $7.74    P/E N/A 
Day Low $7.50    EPS
Volume 38,258